Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 1
2009 2
2010 5
2011 2
2012 2
2013 2
2014 5
2015 4
2016 2
2017 4
2018 8
2019 9
2020 19
2021 25
2022 32
2023 15
2024 32
2025 34
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
MiniMedTM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics.
Kountouri A, Ikonomidis I, Katogiannis K, Thymis J, Pavlidis G, Korakas E, Pliouta L, Agapitou V, Liatis S, Petrovski G, Dimitriadis GD, Lambadiari V. Kountouri A, et al. Among authors: lambadiari v. Diabetes Technol Ther. 2026 Feb 5:15209156261417289. doi: 10.1177/15209156261417289. Online ahead of print. Diabetes Technol Ther. 2026. PMID: 41645534
Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trials.
Stefanou MI, Panagiotopoulos E, Tentolouris A, Theodorou A, Papagiannopoulou G, Athanasaki A, Tsalouchidou PE, Peppa M, Lambadiari V, Konitsiotis S, Mengel A, Paraskevas GP, Tentolouris N, Tsivgoulis G. Stefanou MI, et al. Among authors: lambadiari v. Ther Adv Neurol Disord. 2026 Jan 31;19:17562864251408269. doi: 10.1177/17562864251408269. eCollection 2026. Ther Adv Neurol Disord. 2026. PMID: 41631108 Free PMC article.
Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysis.
Stefanou MI, Tentolouris A, Panagiotopoulos E, Theodorou A, Mengel A, Athanasaki A, Lambadiari V, Peppa M, Papadopoulou M, Paraskevas GP, Giannopoulos S, Siasos G, Sharma VK, Ziemann U, Tsivgoulis G. Stefanou MI, et al. Among authors: lambadiari v. J Diabetes Complications. 2026 Jan 26;40(3):109271. doi: 10.1016/j.jdiacomp.2026.109271. Online ahead of print. J Diabetes Complications. 2026. PMID: 41619622
GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination: effects on carotid atherosclerosis regression, oxidative stress, and amyloid-β1-40 in diabetes.
Ikonomidis I, Papageorgiou A, Pavlidis G, Georgiopoulos G, Katogiannis K, Maratou E, Thymis J, Pliouta L, Kountouri A, Korakas E, Kostelli G, Parissis J, Nikolaou PE, Andreadou I, Lambadiari V. Ikonomidis I, et al. Among authors: lambadiari v. Am J Physiol Heart Circ Physiol. 2026 Feb 1;330(2):H610-H619. doi: 10.1152/ajpheart.00996.2025. Epub 2026 Jan 24. Am J Physiol Heart Circ Physiol. 2026. PMID: 41579346
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.
Nicholls SJ, Ryan DH, Deanfield J, Ferreira D, Lang CC, Lincoff AM, Lingvay I, Lübker C, Terns PP, Rasmussen S, Stensen S, Weeke PE, Kahn SE; SELECT Trial Investigators. Nicholls SJ, et al. JAMA Cardiol. 2026 Feb 1;11(2):156-164. doi: 10.1001/jamacardio.2025.4824. JAMA Cardiol. 2026. PMID: 41433034 Clinical Trial.
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Nicholls SJ, Pavo I, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, McGuire DK, Miller D, Nauck MA, Nishiyama H, Nissen SE, Sattar N, Weerakkody G, Wiese RJ, Zinman B, Zoungas S, Basile J, Davies MJ, Giorgino F, Kellerer M, Ji L, Varkonyi T, Menon V, Broder JC, Herschtal A, D'Alessio D; SURPASS-CVOT Investigators. Nicholls SJ, et al. N Engl J Med. 2025 Dec 18;393(24):2409-2420. doi: 10.1056/NEJMoa2505928. N Engl J Med. 2025. PMID: 41406444 Clinical Trial.
Metreleptin In SHORT Syndrome With Uncontrolled Diabetes.
Korakas E, Kountouri A, Ikonomidis I, Georgiou I, Akinci B, Lambadiari V. Korakas E, et al. Among authors: lambadiari v. JCEM Case Rep. 2025 Oct 9;3(11):luaf218. doi: 10.1210/jcemcr/luaf218. eCollection 2025 Nov. JCEM Case Rep. 2025. PMID: 41080980 Free PMC article.
193 results